BioNanomatrix Overview

" BioNanomatrix, Inc (BNM) is a bionanotech designer and maker of nanostructured chips, devices and systems for fast, comprehensive, and low-cost analysis of native state genomic, epigenomic and proteomic information with sensitivity at the single cell / single molecule level. Currently, BNM develops nanodevices and systems for cancer diagnostics, complex disease therapeutics and personalized...More»

" BioNanomatrix, Inc (BNM) is a bionanotech designer and maker of nanostructured chips, devices and systems for fast, comprehensive, and low-cost analysis of native state genomic, epigenomic and proteomic information with sensitivity at the single cell / single molecule level. Currently, BNM develops nanodevices and systems for cancer diagnostics, complex disease therapeutics and personalized medicine on its NANOANALYZER™ platform.

Borne of a six-million dollar Department of Defense project funded by DARPA (Defense Advanced Research Project Agency) at Princeton University, BioNanomatrix is currently one of seven platform startups of Princeton University as it builds upon an already strong portfolio of patents and other intellectual property."

(Source: BioNanomatrix.com)«Less